|
|
High School
|
Ithaca, New York
|
June 1958
|
College
|
University of Rochester, Rochester, New York
Phi Beta Kappa, B.A. Psychology
|
1958-1962
|
Medical School
|
State University of New York
Upstate Medical Center, New York
M.D. with Honors, Alpha Omega Alpha
|
1962-1966
|
Internship
|
Presbyterian Hospital in New York City
|
1966-1967
|
Residency
|
Presbyterian Hospital; General/Vascular Surgery
College of Physician & Surgeons
Columbia University in New York City
|
1967-1972
|
Chief Resident & Vascular Surgery Resident
|
General & Vascular Surgery
Presbyterian Hospital, City of New York
Columbia Presbyterian Medical Center
College of Physicians & Surgeons
|
1972-1973
|
Practice History
|
Palm Beach Medical Group
|
1973-1991
|
|
Private Practice
|
1991-Present
|
Hospital Appointment & Associations
|
Director
|
Center for Breast Care
Columbia Hospital, West Palm Beach
|
1996-Present
|
Founder and Director
|
Center For Breast Health
St. Mary’s Hospital, West Palm Beach
|
1992-1995
|
Hospitals
|
St. Mary’s Hospital
|
1973-Present
|
| |
Good Samaritan Hospital
|
1973-Present
|
| |
Columbia Hospital
|
1989-Present
|
| |
Palm Beach Gardens
|
1990-Present
|
| |
Kimmel Outpatient Surgical Center
|
|
| |
Delray Outpatient & Laser Center
|
|
Research & Publications
|
| |
Focused Microwave Phased Array Thermotherapy for Primary Breast Cancer, Gardner RA, Vargas HI, Block JB et al (Columbia Hosp, West Palm Beach, Fla; Harbor-Univ of California, Torrance; Massachusetts Inst of Technology, Lexington; Breast Diseases: A Year Book Quarterly, Vol 14 No 1 2003
|
April-June 2003
|
| |
The Principal investigator at Columbia Hospital for a FDA approved research to evaluate the safety and effectiveness of the SenoRx Lesion Localization Device
|
2001-Present
|
| |
R.A. Gardner, H.I. Vargas, J. Block, C.L. Vogel, A.J. Fenn, G. Kuehl, M. Doval; Columbia Hospital, West Palm Beach, Florida; Harbor-UCLA Medical Center, Torrance, California; Massachusetts Institute of Technology, Lexington: “Focused Microwave Phased Array (FMPA) Thermotherapy for Primary Breast Cancer”. The abstract presented at The Society of Surgical Oncology, Inc. 54th Annual Cancer Symposium, March 15-18, 2001 in Washington DC.
|
March 2001
|
| |
One of four investigators in the United States and Europe leading a FDA approved 2nd phase research to treat breast cancer with heat (hyperthermia)
|
2001-Present
|
| |
Director - Breast Cancer Prevention Program of Florida
|
2000-Present
|
| |
The investigator for Fine Needle Aspiration Program
|
2000-Present
|
| |
One of two investigators in the United States leading a FDA approved research to treat breast cancer with heat (hyperthermia)
|
1999-Present
|
| |
Investigator for FDA and NSABP Star Trial Study of Tamoxifen vs. Raloxifene
|
1999-Present
|
| |
Director of Sentinel Lymph Node Biopsy, research protocol – Columbia Hospital
|
1996-Present
|
| |
Site investigator – Study Breast Cutaneous Temperature and Tumor Relationship, screening protocol
|
1996-1997
|
| |
Investigator FDA Trial Breast Skin Temperature as a Function of Underlying Benign and Malignant Tumors of Breast
|
1983-1985
|
| |
Study of Pancreatic Surgical Procedures in patients with pain of chronic, relapsing pancreatitis. Gardner, R., Porter, M. – New York Surgical, April 1973
|
1970-1973
|
| |
American Cancer Society Grant
Study of Regional Lymph Node Anti Tumor
Anti Body Production
|
1966-1992
|
| |
The Role of Regional Lymph Nodes in Anti Tumor Anti Body Production-Gardner, R., Decosse, J. – Syracuse Medical Journal
|
1966
|
|
Advanced Training
|
Advanced Training
|
Click Here for Advanced Training |
|
|
|
